These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14617037)

  • 1. Soluble HLA-DR and soluble CD95 ligand levels in pregnant women with antiphospholipid syndromes.
    Rebmann V; Ronin-Walknowska E; Sipak-Szmigiel O; Miklaszewicz A; Czajkowska E; Grosse-Wilde H
    Tissue Antigens; 2003 Dec; 62(6):536-41. PubMed ID: 14617037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the concentration of sHLA-I and selected cytokines in pregnancy complicated by antiphospholipid syndrome.
    Olimpia SS; Magdalena P; Tomasz P; Piotr W; Elzbieta RW
    Ginekol Pol; 2011 May; 82(5):354-8. PubMed ID: 21851034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble HLA-DR levels in the maternal circulation of normal and pathologic pregnancy.
    Steinborn A; Rebmann V; Scharf A; Sohn C; Grosse-Wilde H
    Am J Obstet Gynecol; 2003 Feb; 188(2):473-9. PubMed ID: 12592258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of decreased soluble HLA-G levels in the maternal circulation predicts the occurrence of preeclampsia and intrauterine growth retardation during further course of pregnancy.
    Steinborn A; Varkonyi T; Scharf A; Bahlmann F; Klee A; Sohn C
    Am J Reprod Immunol; 2007 Apr; 57(4):277-86. PubMed ID: 17362389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble HLA class I molecules/CD8 ligation trigger apoptosis of CD8+ cells by Fas/Fas-ligand interaction.
    Puppo F; Contini P; Ghio M; Indiveri F
    ScientificWorldJournal; 2002 Feb; 2():421-3. PubMed ID: 12806026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of circulating fetal DNA as a tool for potential monitoring of pregnant patients with antiphospholipid antibodies.
    Korabecna M; Ulcova-Gallova Z; Horinek A; Pazourková E; Calda P
    Autoimmunity; 2014 Nov; 47(7):473-7. PubMed ID: 24829103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies.
    Martínez-Zamora MA; Tassies D; Carmona F; Espinosa G; Cervera R; Reverter JC; Balasch J
    J Reprod Immunol; 2010 Nov; 86(2):133-40. PubMed ID: 20594598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between HLA-G 14bp Gene Polymorphism and Serum sHLA-G Protein Concentrations in Preeclamptic Patients and Normal Pregnant Women.
    Rokhafrooz S; Ghadiri A; Ghandil P; Ghafourian M; Hossaini SH; Daraei N; Najafian M; Rouhizadeh A
    Immunol Invest; 2018 Aug; 47(6):558-568. PubMed ID: 29952661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concentrations of soluble HLA-G protein are elevated during mid-gestation and decreased in pre-eclampsia.
    Darmochwal-Kolarz D; Kolarz B; Rolinski J; Leszczynska-Gorzelak B; Oleszczuk J
    Folia Histochem Cytobiol; 2012 Jul; 50(2):286-91. PubMed ID: 22763960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement activation in the plasma and placentas of women with different subsets of antiphospholipid syndrome.
    Scambi C; Ugolini S; Tonello M; Bortolami O; De Franceschi L; Castagna A; Lotti V; Corbella M; Raffaelli R; Caramaschi P; Mattia E; Biasi D; Ruffatti A
    Am J Reprod Immunol; 2019 Dec; 82(6):e13185. PubMed ID: 31479579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between decreased plasma levels of soluble human leukocyte antigen-G and severe pre-eclampsia.
    He Y; Chen S; Huang H; Chen Q
    J Perinat Med; 2016 Apr; 44(3):283-90. PubMed ID: 26352061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Placental abruption is associated with decreased maternal plasma levels of soluble HLA-G.
    Steinborn A; Rebmann V; Scharf A; Sohn C; Grosse-Wilde H
    J Clin Immunol; 2003 Jul; 23(4):307-14. PubMed ID: 12959223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maternal soluble human leukocyte antigen-G levels in pregnancies complicated by foetal intrauterine growth restriction with and without preeclampsia.
    Laskowska M; Laskowska K; Oleszczuk J
    Pregnancy Hypertens; 2012 Apr; 2(2):168-73. PubMed ID: 26105102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble HLA-DR levels in serum are associated with therapy and genetic factors in rheumatoid arthritis.
    Verbruggen LA; Versaen H; Rebmann V; Duquet W; De Cock S; Grosse-Wilde H; Demanet C
    Hum Immunol; 2002 Sep; 63(9):758-64. PubMed ID: 12175730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble HLA levels in early pregnancy after in vitro fertilization.
    Pfeiffer KA; Rebmann V; Pässler M; van der Ven K; van der Ven H; Krebs D; Grosse-Wilde H
    Hum Immunol; 2000 Jun; 61(6):559-64. PubMed ID: 10825584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
    Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
    Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic immunoadsorption increases the level of circulating soluble HLA molecules.
    Poehlau D; Kiltz U; Rieks M; Hoffmann V; Rebmann V; Schimrigk S; Grosse-Wilde H; Przuntek H
    Vox Sang; 2000; 78(2):119-21. PubMed ID: 10765148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble HLA-G concentrations in obese women during pregnancy and in cord blood.
    Beneventi F; Locatelli E; De Amici M; Martinetti M; Spinillo A
    J Reprod Immunol; 2017 Feb; 119():31-37. PubMed ID: 27984763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopes.
    Verbruggen LA; Dumarey N; Van de Velde H; Rebmann V; Flament J; Van Wayenberge C; Grosse-Wilde H; Demanet C
    Tissue Antigens; 2000 Nov; 56(5):436-40. PubMed ID: 11144291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Report: Changes in Antiphospholipid Antibody Titers During Pregnancy: Effects on Pregnancy Outcomes.
    Yelnik CM; Porter TF; Branch DW; Laskin CA; Merrill JT; Guerra MM; Lockshin MD; Buyon JP; Petri M; Sammaritano LR; Stephenson MD; Kim MY; Salmon JE
    Arthritis Rheumatol; 2016 Aug; 68(8):1964-9. PubMed ID: 26990620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.